PORTUGAL BLUE

  • DATABASE (137)

  • ARTICLES (113)

    • DATABASE (137)
    • ARTICLES (113)
  • Sort by
    • Relevance
    • Date

Renamed Defined.ai, DefinedCrowd has expanded into a marketplace for AI data, tools and models, with services for complex ML projects. NLP, computer vision focused. 

BlueRun Ventures China was founded in 2005, focusing on early-stage investment of companies. The investments are usually from US$100,000 to US$10 million.

Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas. 

Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.

Biotech Bluepha has secured close to $100m Series B funding to boost bioplastics production and R&D to develop greener solutions for industrial manufacturers.

Formerly of Baidu, focusing on marketing strategy; and BlueFocus, in media relations.

Ex-Googler Li Zhifei ("Watch Bro") is founder and CEO of advanced voice recognition tech startup Mobvoi, producer of the bestselling TicWatch smartwatch. After graduating from Nanjing University of Science and Technology, Li worked at MobileSoft on WAP and Bluetooth-related projects from 1999-2002. He received his PhD in Computer Science from Johns Hopkins University in 2010. At JHU, he built Joshua, an open-source software for machine translation. Li joined Google in 2010, where he helped create Google's mobile offline translation system. Inspired by the launch and success of Siri released in 2012, he left Google and returned to China to found Mobvoi end-2012.   

Li Teng graduated in bioscience at Tsinghua University in 2011 and stayed on to complete a PhD in synthetic biology in 2016. He joined a SynBio project team to create PHA bioplastics during his postgrad research at university.Li was also the leader of Tsinghua University’s team that won a gold medal at the International Genetically Engineered Machine (iGEM) Design Competition. He met Zhang Haoqian at the iGEM giant jamboree in 2010 and they have remained friends ever since.Li and Zhang co-founded Bluepha in 2016, a spin-off from Tsinghua University’s SynBio research project. In 2018, Li was selected for MIT Technology Review’s list of Innovators under 35. In 2019, he was named one of the 40 Chinese business elites under 40. 

Zhang Haoqian completed a doctorate degree in systems and synthetic biology at Peking University in 2016. He has published more than 20 papers in international academic journals. In 2019, he was honored as one of China's 100 Most Creative People in Business. He is also a member of the Synthetic Biology Committee under China Society of Biotechnology.Peking University has participated in the International Genetically Engineered Machine (iGEM) competitions, with Zhang as a team member or leader between 2008 and 2010. The team has won gold medals twice at the iGEM competitions supported by MIT. He was also coaching the university’s iGEM team from 2011 until 2017. Zhang also founded the committee of China iGEMer Community.In 2010, Zhang met fellow iGEMer and Bluepha co-founder Li Teng at the iGEM giant jamboree event. They co-founded SynBio startup Bluepha in 2016, a spin-off from Tsinghua University.

Trained in mechanical engineering, Alex Raventos graduated from the MIT-Portugal’s Executive Master’s program focused on sustainable energy systems. In 2017 he joined the prestigious Global Solution Program led by Singularity University at NASA Research Park in Mountain View, California, where talents meet to develop innovative technology and groundbreaking solutions that address the greatest challenges for humanity today.Raventos has gained significant experience as head of economics and project coordinator in companies in the energy sector such as WavEC Offshore Renewables and Bluewater.In 2014 he founded Inn2Grid, consulting companies in renewable energy and focused on ocean energy technologies. Since 2017 he has been CEO and co-founder of X1 Wind, a Barcelona-based startup developing a downwind turbine technology to reduce the Levelized Cost of Energy (LCOE) in offshore wind plants.  

Carlos Casanova is the CTO and co-founder of X1 Wind, a company developing a downwind turbine technology to reduce the Levelized Cost of Energy (LCOE) in offshore wind plants, named the PivotBuoy system. He conceived the concept that paved the way for PivotBuoy in 2012 during his MSc studies in Mechanical Engineering at the Massachusetts Institute of Technology (MIT). Prior to X1 Wind, Casanova worked as an engineer in companies developing similar solutions in the field of wind turbines and floating offshore systems, including Bluewater and Adwen Offshore.From 2012 to 2014, Casanova also was Research Assistant at MIT, investigating floating wind turbine advanced controls.

Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO.  Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications,  developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley 

Led by Wang Mengqiu, a former technology VP at Baidu, this early stage TMT-focused venture capital fund was founded in 2012; and counts PP Zuche, Blued, Beequick, and 51Credit among its notable investments. Its self-professed investing style is "conservative," with just 10 investments in the year 2015. Preferred market segments in 2016 include children's, men's, fintech, sports and fitness.fintech, sports and fitness.

Apostolos Apostolakis is a serial entrepreneur turned investor. He has a Civil Engineering degree from NTUA and an MBA from Columbia Business School. His entrepreneurial career started after working two years as a consultant for the Boston Consulting Group until 2004. He became a co-founder and board member of various companies including VentureFriends, InstaShop, Douleutaras.gr, e-food.gr, Doctoranytime.gr and Blueground (formerly Openfund and Taxibeat). In 2010, he started investing in other startups, focusing on e-marketplaces and SaaS.

Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.

Sorry, we couldn’t find any matches for “PORTUGAL BLUE”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.